Kenvue的Q3收入比估计少,但收入没有增加,逐年下降。 Kenvue's Q3 earnings beat estimates but revenue missed and fell year-over-year.

Kenvue公司报告说,第三季度收入为每股0.28美元,略高于估计数,但37.6亿美元的收入低于预期,比上一年下降3.5%。 Kenvue Inc. reported third-quarter earnings of $0.28 per share, slightly above estimates, but revenue of $3.76 billion fell short of expectations and declined 3.5% year-over-year. 该公司是一家消费保健公司,由Johnson & Johnson公司经营,市场上限为326.1亿美元,P/E比率为22.69。 The company, a consumer health firm spun off from Johnson & Johnson, has a market cap of $32.61 billion and a P/E ratio of 22.69. 机构投资者持有97.64%的股份。 Institutional investors own 97.64% of shares. Thomasville国家银行的股份减少了94.6%,而Viking基金管理有限责任有限公司的股份增加了36%。 Thomasville National Bank reduced its stake by 94.6%, while Viking Fund Management LLC increased its holding by 36%. Jeffrey C. Smith主任收购了320万股,将其所有权提高到近2 730万股。 Director Jeffrey C. Smith acquired 3.2 million shares, boosting his ownership to nearly 27.3 million. 分析员预测2025年全年收入为1.14美元, " 稳住 " 评级一致,目标价格为20.23美元。 Analysts project full-year 2025 earnings of $1.14, with a consensus "Hold" rating and a target price of $20.23.